11 results
8-K
EX-10.8
BIAF
BioAffinity Technologies Inc
20 Sep 23
Entry into a Material Definitive Agreement
4:52pm
grammatical changes required to make the provisions hereof apply either to corporations or partnerships or individuals, men or women, as the case may require
DRS
BIAF
BioAffinity Technologies Inc
14 Aug 23
Draft registration statement
12:00am
on the leading cause of cancer death among both men and women. Lung cancer accounted for approximately 18% of all cancer deaths worldwide in 2020, as reported … , CyPath® Lung, focuses on the leading cause of cancer death among both men and women. Lung cancer accounted for approximately 18% of all cancer deaths
8-K
EX-99.1
BIAF
BioAffinity Technologies Inc
15 Dec 22
Other Events
1:26pm
and women are innovative, dedicated and committed to commercialization of CyPath® Lung and development of additional diagnostics for lung diseases
424B4
BIAF
BioAffinity Technologies Inc
2 Sep 22
Prospectus supplement with pricing info
3:25pm
death among both men and women. Each year, more people die of lung cancer than of colon, breast, and prostate cancers combined, making up almost 18
S-1
fuckfv5pfum wvpq7zi
25 Apr 22
IPO registration
6:16am
- Prev
- 1
- Next